Literature DB >> 31666385

Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.

Matthew L Scott1, Brittany L Woodby1, Joseph Ulicny2, Gaurav Raikhy1, A Wayne Orr3, William K Songock4, Jason M Bodily5.   

Abstract

Human papillomaviruses (HPVs) infect keratinocytes of stratified epithelia. Long-term persistence of infection is a critical risk factor for the development of HPV-induced malignancies. Through the actions of its oncogenes, HPV evades host immune responses to facilitate its productive life cycle. In this work, we discovered a previously unknown function of the HPV16 E5 oncoprotein in the suppression of interferon (IFN) responses. This suppression is focused on keratinocyte-specific IFN-κ and is mediated through E5-induced changes in growth factor signaling pathways, as identified through phosphoproteomics analysis. The loss of E5 in keratinocytes maintaining the complete HPV16 genome results in the derepression of IFNK transcription and subsequent JAK/STAT-dependent upregulation of several IFN-stimulated genes (ISGs) at both the mRNA and protein levels. We also established a link between the loss of E5 and the subsequent loss of genome maintenance and stability, resulting in increased genome integration.IMPORTANCE Persistent human papillomavirus infections can cause a variety of significant cancers. The ability of HPV to persist depends on evasion of the host immune system. In this study, we show that the HPV16 E5 protein can suppress an important aspect of the host immune response. In addition, we find that the E5 protein is important for helping the virus avoid integration into the host genome, which is a frequent step along the pathway to cancer development.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  E5; EGFR; STAT signaling; TGFBR2; innate immunity; interferon kappa; papillomavirus

Mesh:

Substances:

Year:  2020        PMID: 31666385      PMCID: PMC6955282          DOI: 10.1128/JVI.01582-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  131 in total

1.  IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.

Authors:  Correne A DeCarlo; Alberto Severini; Lutz Edler; Nicholas G Escott; Paul F Lambert; Marina Ulanova; Ingeborg Zehbe
Journal:  Lab Invest       Date:  2010-05-17       Impact factor: 5.662

2.  Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.

Authors:  Brittany L Woodby; William K Songock; Matthew L Scott; Gaurav Raikhy; Jason M Bodily
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

3.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.

Authors:  Mark R Pett; M Trent Herdman; Roger D Palmer; Giles S H Yeo; Mahmud K Shivji; Margaret A Stanley; Nicholas Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

Authors:  D Patel; S M Huang; L A Baglia; D J McCance
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

5.  The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes.

Authors:  K Crusius; I Rodriguez; A Alonso
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

6.  Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study.

Authors:  Stuart I Collins; Christothea Constandinou-Williams; Kaisheng Wen; Lawrence S Young; Sally Roberts; Paul G Murray; Ciaran B J Woodman
Journal:  Cancer Res       Date:  2009-04-28       Impact factor: 12.701

7.  The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.

Authors:  Laurence Feldmeyer; Martin Keller; Gisela Niklaus; Daniel Hohl; Sabine Werner; Hans-Dietmar Beer
Journal:  Curr Biol       Date:  2007-07-03       Impact factor: 10.834

Review 8.  Molecular biology of human papillomavirus infection and cervical cancer.

Authors:  John Doorbar
Journal:  Clin Sci (Lond)       Date:  2006-05       Impact factor: 6.124

Review 9.  DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story.

Authors:  Peter W S Hill; Rachel Amouroux; Petra Hajkova
Journal:  Genomics       Date:  2014-08-27       Impact factor: 5.736

10.  Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle.

Authors:  Christopher W Wasson; Ethan L Morgan; Marietta Müller; Rebecca L Ross; Margaret Hartley; Sally Roberts; Andrew Macdonald
Journal:  Oncotarget       Date:  2017-10-06
View more
  24 in total

1.  Apoptotic caspases suppress an MDA5-driven IFN response during productive replication of human papillomavirus type 31.

Authors:  Ning Huang; Des'ree Groover; Blossom Damania; Cary Moody
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-11       Impact factor: 12.779

Review 2.  Biology of HPV Mediated Carcinogenesis and Tumor Progression.

Authors:  Pippa F Cosper; Samantha Bradley; Lexi Luo; Randall J Kimple
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

3.  The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.

Authors:  Alexandra D Torres; Megan E Spurgeon; Andrea Bilger; Simon Blaine-Sauer; Aayushi Uberoi; Darya Buehler; Stephanie M McGregor; Ella Ward-Shaw; Paul F Lambert
Journal:  Virology       Date:  2019-12-05       Impact factor: 3.616

Review 4.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

Review 5.  Human papillomaviruses: diversity, infection and host interactions.

Authors:  Alison A McBride
Journal:  Nat Rev Microbiol       Date:  2021-09-14       Impact factor: 60.633

6.  Two conserved amino acids differentiate the biology of high-risk and low-risk HPV E5 proteins.

Authors:  Sawali R Sudarshan; Richard Schlegel; Xuefeng Liu
Journal:  J Med Virol       Date:  2022-05-14       Impact factor: 20.693

Review 7.  Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.

Authors:  Adriana Gutiérrez-Hoya; Isabel Soto-Cruz
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

8.  Bovine Delta Papillomavirus E5 Oncoprotein Interacts With TRIM25 and Hampers Antiviral Innate Immune Response Mediated by RIG-I-Like Receptors.

Authors:  Francesca De Falco; Anna Cutarelli; Ivan Gentile; Pellegrino Cerino; Valeria Uleri; Adriana Florinela Catoi; Sante Roperto
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 9.  Activating the DNA Damage Response and Suppressing Innate Immunity: Human Papillomaviruses Walk the Line.

Authors:  Claire D James; Dipon Das; Molly L Bristol; Iain M Morgan
Journal:  Pathogens       Date:  2020-06-13

10.  Suppression of a Subset of Interferon-Induced Genes by Human Papillomavirus Type 16 E7 via a Cyclin Dependent Kinase 8-Dependent Mechanism.

Authors:  Sadie Rice; Seong-Man Kim; Cynthia Rodriguez; William Songock; Gaurav Raikhy; Rebecca Lopez; Lauren Henderson; Arjun Yusufji; Jason Bodily
Journal:  Viruses       Date:  2020-03-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.